Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
Imran Howell(Institute of Cancer Research), Ian Pavord(Oxford BioMedica (United Kingdom)), Timothy Hinks(University of Oxford), Mona Bafadhel(National Institute for Health and Care Research), J. Mark Melhorn(University Hospital of Wales), Mahdi Mahdi(National Institute for Health and Care Research), Maisha Jabeen(Government Sadiq College Women University), Sanjay Ramakrishnan(Oxford BioMedica (United Kingdom))
Cited by 9
Related Papers
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
|The Lancet Respiratory Medicine|2015|584
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
|The Lancet Respiratory Medicine|2021|434
Benralizumab for the Prevention of COPD Exacerbations
|New England Journal of Medicine|2019|329